Individual and Social Network Factors that Predict Entry to Drug Treatment

References

• Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2004 National Survey on Drug Use and Health. SMS 05-4061, NSDUH H-27. Rockville, Md.: Office of Applied Studies; 2005.
   Google Scholar
• French MT, McGeary KA, Chitwood DD, McCoy CB, Inciardi JA, McBride D. Chronic drug use and crime. Subst Abuse. 2000;21:95–109.
   PubMedGoogle Scholar
• El-Bassel N, Gilbert L, Wu E, Ho H, Hill J. Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am J Public Health. 2005;95:465–470.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program. British Journal of Addiction. 1992;87:493–498.
   PubMedGoogle Scholar
• Wechsberg WM, Lam WK, Zule W, Hall G, Middlesteadt R, Edwards J. Violence, homelessness, and HIV risk among crack-using African-American women. Subst Use Misuse. 2003;38:669–700.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Anderson J. Overview of five-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25:125–134.
   PubMed Web of Science ®Google Scholar
• Simpson DD, Joe GW, Broome KM. A national five-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 2002;59:538–544.
   PubMed Web of Science ®Google Scholar
• Sorensen JL, Copeland JA. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17–31.
   PubMed Web of Science ®Google Scholar
• Metzger DS, Navaline H. Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clin Infect Dis. 2003;37(Suppl. 5):S451–S456.
   PubMed Web of Science ®Google Scholar
• Shah NG, Celentano DD, Vlahov D, , et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS. 2000;14:2035–2043.
   PubMed Web of Science ®Google Scholar
• Hser YI, Maglione M, Polinsky ML, Anglin MD. Predicting drug treatment entry among treatment-seeking individuals. J Subst Abuse Treat. 1998;15:213–220.
   PubMed Web of Science ®Google Scholar
• Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994;36:129–138.
   PubMed Web of Science ®Google Scholar
• Siegal HA, Falck RS, Wang J, Carlson RG. Predictors of drug abuse treatment entry among crack-cocaine smokers. Drug Alcohol Depend. 2002;68:159–166.
   PubMed Web of Science ®Google Scholar
• Zule WA, Desmond D. Factors predicting entry of injecting drug users into substance abuse treatment. Am J Drug Alcohol Abuse. 2000;26:247–261.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24:305–311.
   PubMed Web of Science ®Google Scholar
• McCusker J, Willis G, McDonald M, Lewis BF, Sereti SM, Feldman ZT. Admissions of injection drug users to drug abuse treatment following HIV counseling and testing. Public Health Rep. 1994;109(2):212–218.
   PubMed Web of Science ®Google Scholar
• Beardsley K, Wish ED, Fitzelle DB, O'Grady K, Arria AM. Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat. 2003;25:279–285.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Milkulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004;74:177–185.
   PubMed Web of Science ®Google Scholar
• Schroeder JR, Latkin CA, Hoover DR, Curry AD, Knowlton AR, Celentano DD. Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann Epidemiol. 2001;11:389–394.
   PubMed Web of Science ®Google Scholar
• Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend. 2001;65:65–75.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Knowlton AR, Hoover DR, Mandell W. Drug network characteristics as a predictor of cessation of opiate use among adult injection drug users: a prospective study. Am J Drug Alcohol Abuse. 1999;25:463–473.
   PubMed Web of Science ®Google Scholar
• Broome KM, Simpson DD, Joe GW. The role of social support following short-term inpatient treatment. Am J Addict. 2002;11:57–65.
   PubMed Web of Science ®Google Scholar
• Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Recovery from opioid addiction in DATOS. J Subst Abuse Treat. 2003;25:177–186.
   PubMed Web of Science ®Google Scholar
• Lloyd JJ, Ricketts EP, Strathdee SA, , et al. Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am J Drug Alcohol Abuse. 2005;31:555–570.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Sherman S, Knowlton AR. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychology. 2003;22:332–339.
   PubMed Web of Science ®Google Scholar
• National Institute of Drug Abuse. Risk Behavior Assessment (RBA) Questionnaire. Rockville, Md.: Community Research Branch, National Institute on Drug Abuse, Alcohol, Drug Abuse, and Mental Health Administration; 1991.
   Google Scholar
• Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DA. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. Journal of Acquired Immunodeficiency Syndromes and Human Retrovirology. 1996;13:273–280.
   PubMedGoogle Scholar
• Deren S, Beardsley M, Coyle S, Singer M. HIV serostatus and risk behaviors in a multisite sample of drug users. J Psychoactive Drugs. 1998;30:239–245.
   PubMed Web of Science ®Google Scholar
• MacGowan RJ, Fichtner RR, Swanson N, Collier C, Kroliczak A, Cole G. Factors associated with client-reported HIV infection among clients entering methadone treatment. AIDS Educ Prev. 1997;9:205–217.
   PubMedGoogle Scholar
• Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22:223–228.
   PubMed Web of Science ®Google Scholar
• Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988–2000: description and determinants. Am J Epidemiol. 2003;158:695–704.
   PubMed Web of Science ®Google Scholar
• Galantar M, Dermatis H, Keller D, Trujillo M. Network therapy for cocaine abuse: use of family and peer supports. Am J Addict. 2002;11:161–166.
   Google Scholar
• Laudet AB, Cleland CM, Magura A, Vogel HS, Knight EL. Social support mediates the effects of dual-focus mutual aid groups on abstinence from substance use. Am J Psychol. 2004;34:175–185.
   Google Scholar
• Caldwell PE, Cutter HSG. Alcoholics Anonymous affiliation during early recovery. J Subst Abuse Treat. 2005;15:221–228.
   Google Scholar
• Crape BL, Latkin CA, Laris AS, Knowlton AR. The effects of sponsorship in twelve-step treatment of injection drug users. Drug Alcohol Depend. 2002;65:291–301.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88:517–525.
   PubMed Web of Science ®Google Scholar